Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine

A blood clot is less risky than Covid says CDC

The risk of dying from Covid-19 is 40 times the risk of developing a rare blood clotting condition after getting the Johnson & Johnson vaccine, a CNN analysis shows.

The US Centers for Disease Control and Prevention said Wednesday it has received reports of 28 people who have developed a rare blood clotting syndrome out of 8.7 million given J&J's Janssen coronavirus vaccine. Three of them have died from the condition, known as thrombosis with thrombocytopenia syndrome (TTS).

However, in that same time period -- March 2 to May 7 -- more than 2.2 million people were diagnosed with Covid-19 and more than 43,000 died, according to data from Johns Hopkins University.
In a group of about 8.7 million people, that scales to nearly 59,000 new Covid-19 cases reported in the past two months and nearly 1,150 new Covid-19 deaths, more than 40 times the number of reported and confirmed cases of TTS.

The chances that a person vaccinated with the J&J vaccine will develop TTS are less than one in 300,000, according to CDC data. But in the past two months, about one in every 7,600 Americans has died of Covid-19.
The CDC has said TTS is plausibly linked to J&J's Janssen vaccine but has said the benefits of the vaccine nonetheless outweigh the risk. All cases have been seen in people ages 18 to 59.

"Most of these TTS cases are occurring in the 30-49-year-old age group," CDC's Dr. Tom Shimabukuro told a meeting of the CDC's Advisory Committee on Immunization Practices.

While most cases were among women, six cases were reported among men, Shimabukuro said. He said 19 had a type of brain blood clot called thrombosis of the cerebral venous sinus, or CVST, while others had different types of blood clots.

The CDC has alerted doctors and patients about the possibility of the complication so it can be recognized and treated promptly and properly.
"There were no cases with a known or documented coagulation disorder," Shimabukuro said. That indicates it's difficult to predict who might develop the condition.
Get CNN Health's weekly newsletter
Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.

"It is important to recognize TTS early and initiate appropriate treatment," he added. "TTS is a rare, clinically serious and life-threatening condition."
TTS has also been linked to AstraZeneca's coronavirus vaccine, which is not authorized for use in the US but is in wide use in Britain and Europe.

Tags : #JJVaccine #Covid19Vaccine #JohnsonandJohnson #CDC #FDA #CovidVaccine

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Hidden Dangers for Diabetic Men: Increased Complications and Prevention StrategiesMay 24, 2024
The Cost of Poverty: How Low-Income Teens Face Greater Health ChallengesMay 24, 2024
Combatting Employee Burnout in the Face of Constant Crises: Insights from International SOS’s Risk Outlook 2024May 24, 2024
The Hidden Danger in Freshwater: A Young Girl's Fight Against PAMMay 24, 2024
The Dangers of Ultra-Processed Foods: A Wake-Up Call for Health Conscious IndiansMay 23, 2024
Can Intermittent Fasting Protect Against Liver Cancer? Here’s What the Science SaysMay 23, 2024
Easier, Faster Claims: The Impact of the National Claim Exchange PortalMay 23, 2024
Can Nightmares Predict Autoimmune Flares? Insights from a Groundbreaking StudyMay 23, 2024
Does Parent-Led Singing Improve Development in Preterm Infants? A Comprehensive StudyMay 22, 2024
Biohacking 101: Boosting Physical and Mental Well-beingMay 22, 2024
In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024